Philip Roelandt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Philip Roelandt has a total of 158 co-authors. Here are the top co-authors by number of shared publications:
- Raf Bisschops
University Hospitals Leuven, KU Leuven, Belgium
8 shared publications - Catherine M. Verfaillie
Department of Development and Regeneration, Stem Cell Institute, KU Leuven, Leuven, Belgium
4 shared publications - Cesare Hassan
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy
4 shared publications - David Cassiman
Department of Gastroenterology-Hepatology and Metabolic Center, Catholic University Leuven, Leuven, Belgium
4 shared publications - Frederik Maes
KU Leuven
4 shared publications - Ingrid Demedts
Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium
4 shared publications
Latest Publications
- Top Cited Papers
- 21 July 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (10) , 1142-1179
Sedation for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Guideline
Main Recommendations: ESGE and ESGENA recommend that informed consent for gastrointestinal endoscopic procedures should include consent for sedation and cover best practice as outlined in the ESGE Position Statement for informed consent.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend pre-assessment, a specific sedation regimen, and enhanced periprocedural monitoring in high-risk patients undergoing gastrointestinal procedures with sedation, to reduce the risk of sedation-related adverse events.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend that pre-assessment, sedation regimen, and periprocedural monitoring should be determined by the complexity (duration, invasiveness) of the endoscopic procedure.Strong recommendation, very low certainty of evidence. ESGE and ESGENA suggest that the management of sedation in patients on glucagon-like peptide-1 receptor agonists should be individualized. Conditional recommendation, very low certainty of evidence. ESGE and ESGENA suggest offering the option of diagnostic colonoscopy and gastroscopy without sedation, based on the patient’s and endoscopist’s preference.Conditional recommendation, very low certainty of evidence. ESGE and ESGENA recommend that sedation should be provided by a dedicated healthcare professional trained in sedation administration and patient monitoring.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend propofol for procedural sedation, as first line, depending on the country’s human resources, service framework, and legislation.ESGE and ESGENA recommend midazolam for procedural sedation, in combination with opiates when analgesia is required.Strong recommendation, very low certainty of evidence. ESGE and ESGENA suggest the provision of the ultrashort-acting sedative remimazolam in elderly patients and patients with cardiovascular and/or respiratory comorbidities.Conditional recommendation, low certainty of evidence. ESGE and ESGENA suggest exercising caution when combining ultrashort-acting sedatives with other sedatives or analgesics.Conditional recommendation, low certainty of evidence. ESGE and ESGENA suggest capnography monitoring for patients undergoing sedated gastrointestinal endoscopy who are at higher risk of hypoxemia.Conditional recommendation, very low certainty of evidence. ESGE and ESGENA recommend that the use of reversal agents should be restricted to managing sedation-analgesia adverse events that do not improve with nonpharmacological intervention.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend that patients be monitored after endoscopy by trained and qualified staff until the return of the patient’s baseline observations.Strong recommendation, very low certainty of evidence. ESGE and ESGENA suggest using scoring systems and standardized discharge checklists to facilitate patient readiness for discharge. Assessments should include a detailed record of vital signs, pain levels, and psychomotor performance.Conditional recommendation, very low certainty of evidence. ESGE and ESGENA suggest that the performing endoscopist holds the overall medicolegal responsibility for the patient’s treatment, including safe recovery, but may delegate the assessment and discharge to trained and qualified personnel based on standardized discharge criteria.Conditional recommendation, very low certainty of evidence. ESGE and ESGENA recommend that patients receive oral and written information regarding the post-endoscopy period. Contact details should be provided for potential delayed complications, emergencies, or readmission.ESGE and ESGENA recommend that patients undergoing sedated endoscopy have an accompanying person at discharge.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend performing emergency endoscopy under moderate sedation in hemodynamically stable patients. Alternatively, emergency endoscopy without sedation in cooperative patients is feasible.ESGE and ESGENA recommend sedation administration by an anesthesiology specialist in emergency endoscopy in patients at increased risk of aspiration, or with hemodynamic instability or significant comorbidities.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend consultation with anesthetic and obstetric teams involved in the pregnant patient`s care, together with the patient’s choice for the appropriateness and choice of sedation during gastrointestinal endoscopy.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend improving and expanding educational offerings on sedation strategies and the principles of airway management, using structured training.Strong recommendation, low certainty of evidence. ESGE and ESGENA recommend the development and implementation of a quality improvement program with performance indicators to monitor the quality of sedation practices in gastrointestinal endoscopy.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend a rational use of sedatives to reduce the environmental impact of endoscopy.Strong recommendation, moderate certainty of evidence.
- 21 July 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (10) , 1142-1179
Top Cited PapersSedation for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Guideline
Main Recommendations: ESGE and ESGENA recommend that informed consent for gastrointestinal endoscopic procedures should include consent for sedation and cover best practice as outlined in the ESGE Position Statement for informed consent.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend pre-assessment, a specific sedation regimen, and enhanced periprocedural monitoring in high-risk patients undergoing gastrointestinal procedures with sedation, to reduce the risk of sedation-related adverse events.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend that pre-assessment, sedation regimen, and periprocedural monitoring should be determined by the complexity (duration, invasiveness) of the endoscopic procedure.Strong recommendation, very low certainty of evidence. ESGE and ESGENA suggest that the management of sedation in patients on glucagon-like peptide-1 receptor agonists should be individualized. Conditional recommendation, very low certainty of evidence. ESGE and ESGENA suggest offering the option of diagnostic colonoscopy and gastroscopy without sedation, based on the patient’s and endoscopist’s preference.Conditional recommendation, very low certainty of evidence. ESGE and ESGENA recommend that sedation should be provided by a dedicated healthcare professional trained in sedation administration and patient monitoring.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend propofol for procedural sedation, as first line, depending on the country’s human resources, service framework, and legislation.ESGE and ESGENA recommend midazolam for procedural sedation, in combination with opiates when analgesia is required.Strong recommendation, very low certainty of evidence. ESGE and ESGENA suggest the provision of the ultrashort-acting sedative remimazolam in elderly patients and patients with cardiovascular and/or respiratory comorbidities.Conditional recommendation, low certainty of evidence. ESGE and ESGENA suggest exercising caution when combining ultrashort-acting sedatives with other sedatives or analgesics.Conditional recommendation, low certainty of evidence. ESGE and ESGENA suggest capnography monitoring for patients undergoing sedated gastrointestinal endoscopy who are at higher risk of hypoxemia.Conditional recommendation, very low certainty of evidence. ESGE and ESGENA recommend that the use of reversal agents should be restricted to managing sedation-analgesia adverse events that do not improve with nonpharmacological intervention.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend that patients be monitored after endoscopy by trained and qualified staff until the return of the patient’s baseline observations.Strong recommendation, very low certainty of evidence. ESGE and ESGENA suggest using scoring systems and standardized discharge checklists to facilitate patient readiness for discharge. Assessments should include a detailed record of vital signs, pain levels, and psychomotor performance.Conditional recommendation, very low certainty of evidence. ESGE and ESGENA suggest that the performing endoscopist holds the overall medicolegal responsibility for the patient’s treatment, including safe recovery, but may delegate the assessment and discharge to trained and qualified personnel based on standardized discharge criteria.Conditional recommendation, very low certainty of evidence. ESGE and ESGENA recommend that patients receive oral and written information regarding the post-endoscopy period. Contact details should be provided for potential delayed complications, emergencies, or readmission.ESGE and ESGENA recommend that patients undergoing sedated endoscopy have an accompanying person at discharge.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend performing emergency endoscopy under moderate sedation in hemodynamically stable patients. Alternatively, emergency endoscopy without sedation in cooperative patients is feasible.ESGE and ESGENA recommend sedation administration by an anesthesiology specialist in emergency endoscopy in patients at increased risk of aspiration, or with hemodynamic instability or significant comorbidities.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend consultation with anesthetic and obstetric teams involved in the pregnant patient`s care, together with the patient’s choice for the appropriateness and choice of sedation during gastrointestinal endoscopy.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend improving and expanding educational offerings on sedation strategies and the principles of airway management, using structured training.Strong recommendation, low certainty of evidence. ESGE and ESGENA recommend the development and implementation of a quality improvement program with performance indicators to monitor the quality of sedation practices in gastrointestinal endoscopy.Strong recommendation, very low certainty of evidence. ESGE and ESGENA recommend a rational use of sedatives to reduce the environmental impact of endoscopy.Strong recommendation, moderate certainty of evidence.
- 28 March 2025
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 36 (7) , 595-596
A male patient with Chlamydia peritonitis: Case report
Pelvic inflammatory disease (PID) is a well-known entity in women. However, on rare occasions, men can present with peritonitis caused by Chlamydia trachomatis as well. It is important to know and recognise this entity in order to avoid unnecessary investigations and commence prompt treatment.
- 28 March 2025
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 36 (7) , 595-596
A male patient with Chlamydia peritonitis: Case report
Pelvic inflammatory disease (PID) is a well-known entity in women. However, on rare occasions, men can present with peritonitis caused by Chlamydia trachomatis as well. It is important to know and recognise this entity in order to avoid unnecessary investigations and commence prompt treatment.
- Open Access
- 1 January 2025
- Published by Hellenic Society of Gastroenterology in Annals of Gastroenterology
- Vol. 38 (6) , 1-11
Non-pharmacological techniques complementary to sedation administration decrease pain and anxiety during gastrointestinal endoscopic procedures: a meta-analysis
We performed a meta-analysis to assess the effect of non-pharmacological techniques, such as virtual reality (VR) and music, as adjuncts to sedation administration during gastrointestinal (GI) endoscopic procedures. We performed a systematic review across MEDLINE and Cochrane Central Register libraries of randomized controlled trials (RCTs), published between 2014 and 2024, evaluating how non-pharmacological techniques affected patients’ reported pain (primary outcome), and anxiety and satisfaction (secondary outcomes), during endoscopy. We performed pairwise meta-analyses and expressed the effect size on study outcomes. We assessed the quality of evidence using Grading of Recommendations Assessment, Development and Evaluation approach. Twelve RCTs analyzing outcomes from 1511 patients (non-pharmacological techniques n=762; standard sedation n=749) were included. Compared to the sedation-only group, application of non-pharmacological techniques resulted overall in significantly lower pain as mean difference [MD] -1.02, 95% confidence interval [CI] -1.64 to -0.41; I2=64%) and anxiety (MD -1.07, 95%CI -1.75 to -0.39; I2=20%), with higher satisfaction (MD 1.67, 95%CI 0.50-2.84; I2=94%). There was low confidence in the estimates, due to the possibility of performance and detection bias in the majority of the studies, and the high level of heterogeneity. This effect regarding reported pain was consistent for virtual reality (3 RCTs, n=241) and music (10 RCTs, n=1270): MD -1.05, 95%CI -1.74 to -0.37; I2=0%, and MD -1.00, 95%CI -1.80 to -0.20; I2=73%, respectively. Concomitant application of virtual reality and/or music as adjuncts to sedation administration during GI endoscopic procedures decreases pain and anxiety, at the same improving time patient satisfaction.
- 1 January 2025
- Published by Hellenic Society of Gastroenterology in Annals of Gastroenterology
- Vol. 38 (6) , 1-11
Open AccessNon-pharmacological techniques complementary to sedation administration decrease pain and anxiety during gastrointestinal endoscopic procedures: a meta-analysis
We performed a meta-analysis to assess the effect of non-pharmacological techniques, such as virtual reality (VR) and music, as adjuncts to sedation administration during gastrointestinal (GI) endoscopic procedures. We performed a systematic review across MEDLINE and Cochrane Central Register libraries of randomized controlled trials (RCTs), published between 2014 and 2024, evaluating how non-pharmacological techniques affected patients’ reported pain (primary outcome), and anxiety and satisfaction (secondary outcomes), during endoscopy. We performed pairwise meta-analyses and expressed the effect size on study outcomes. We assessed the quality of evidence using Grading of Recommendations Assessment, Development and Evaluation approach. Twelve RCTs analyzing outcomes from 1511 patients (non-pharmacological techniques n=762; standard sedation n=749) were included. Compared to the sedation-only group, application of non-pharmacological techniques resulted overall in significantly lower pain as mean difference [MD] -1.02, 95% confidence interval [CI] -1.64 to -0.41; I2=64%) and anxiety (MD -1.07, 95%CI -1.75 to -0.39; I2=20%), with higher satisfaction (MD 1.67, 95%CI 0.50-2.84; I2=94%). There was low confidence in the estimates, due to the possibility of performance and detection bias in the majority of the studies, and the high level of heterogeneity. This effect regarding reported pain was consistent for virtual reality (3 RCTs, n=241) and music (10 RCTs, n=1270): MD -1.05, 95%CI -1.74 to -0.37; I2=0%, and MD -1.00, 95%CI -1.80 to -0.20; I2=73%, respectively. Concomitant application of virtual reality and/or music as adjuncts to sedation administration during GI endoscopic procedures decreases pain and anxiety, at the same improving time patient satisfaction.
- Open Access
Clinical consequences of computer-aided colorectal polyp detection
Background and aim Randomised trials show improved polyp detection with computer-aided detection (CADe), mostly of small lesions. However, operator and selection bias may affect CADe’s true benefit. Clinical outcomes of increased detection have not yet been fully elucidated. Methods In this multicentre trial, CADe combining convolutional and recurrent neural networks was used for polyp detection. Blinded endoscopists were monitored in real time by a second observer with CADe access. CADe detections prompted reinspection. Adenoma detection rates (ADR) and polyp detection rates were measured prestudy and poststudy. Histological assessments were done by independent histopathologists. The primary outcome compared polyp detection between endoscopists and CADe. Results In 946 patients (51.9% male, mean age 64), a total of 2141 polyps were identified, including 989 adenomas. CADe was not superior to human polyp detection (sensitivity 94.6% vs 96.0%) but outperformed them when restricted to adenomas. Unblinding led to an additional yield of 86 true positive polyp detections (1.1% ADR increase per patient; 73.8% were Conclusion Even if CADe appears to be slightly more sensitive than human endoscopists, the additional gain in ADR was minimal and follow-up intervals rarely changed. Additional inspection of non-neoplastic lesions was increased, adding to the inspection and/or polypectomy workload.
Open AccessClinical consequences of computer-aided colorectal polyp detection
Background and aim Randomised trials show improved polyp detection with computer-aided detection (CADe), mostly of small lesions. However, operator and selection bias may affect CADe’s true benefit. Clinical outcomes of increased detection have not yet been fully elucidated. Methods In this multicentre trial, CADe combining convolutional and recurrent neural networks was used for polyp detection. Blinded endoscopists were monitored in real time by a second observer with CADe access. CADe detections prompted reinspection. Adenoma detection rates (ADR) and polyp detection rates were measured prestudy and poststudy. Histological assessments were done by independent histopathologists. The primary outcome compared polyp detection between endoscopists and CADe. Results In 946 patients (51.9% male, mean age 64), a total of 2141 polyps were identified, including 989 adenomas. CADe was not superior to human polyp detection (sensitivity 94.6% vs 96.0%) but outperformed them when restricted to adenomas. Unblinding led to an additional yield of 86 true positive polyp detections (1.1% ADR increase per patient; 73.8% were Conclusion Even if CADe appears to be slightly more sensitive than human endoscopists, the additional gain in ADR was minimal and follow-up intervals rarely changed. Additional inspection of non-neoplastic lesions was increased, adding to the inspection and/or polypectomy workload.
- 9 August 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (10) , 952-966
Informed consent for endoscopic procedures: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
Main statements: All endoscopic procedures are invasive and carry risk. Accordingly, all endoscopists should involve the patient in the decision-making process about the most appropriate endoscopic procedure for that individual, in keeping with a patient’s right to self-determination and autonomy. Recognition of this has led to detailed guidelines on informed consent for endoscopy in some countries, but in many no such guidance exists; this may lead to variations in care and exposure to risk of litigation. In this document, the European Society of Gastrointestinal Endoscopy (ESGE) sets out a series of statements that cover best practice in informed consent for endoscopy. These statements should be seen as a minimum standard of practice, but practitioners must be aware of and adhere to the law in their own country. 1 Patients should give informed consent for all gastrointestinal endoscopic procedures for which they have capacity to do so. 2 The healthcare professional seeking consent for an endoscopic procedure should ensure that the patient has the capacity to consent to that procedure. 3 For patients who lack capacity, healthcare personnel should at all times try to engage with people close to the patient, such as family, friends, or caregivers, to achieve consensus on the appropriateness of performing the procedure. 4 Where a patient lacks capacity to provide informed consent, the best interest decision should be clearly documented in the medical record. This should include information about the capacity assessment, reason(s) that the decision cannot be delayed for capacity recovery (or if recovery is not expected), who has been consulted, and where relevant the form of authority for the decision. 5 There should be a systematic and transparent disclosure of the expected benefits and harms that may reasonably affect patient choice on whether or not to undergo any diagnostic or interventional endoscopic procedure. Information about possible alternatives, as well as the consequences of doing nothing, should also be provided when relevant. 6 The information provided on the benefit and harms of an endoscopic procedure should be adapted to the procedure and patient-specific risk factors, and the preferences of the patient should be central to the consent process. 7 The consent discussion should be undertaken by an individual who is familiar with the procedure and its risks, and is able to discuss these in the context of the individual patient. 8 Patients should confirm consent to an endoscopic procedure in a private, unrushed, and non-coercive environment. 9 If a patient requests that an endoscopic procedure be discontinued, the procedure should be paused and the patient's capacity for decision making assessed. If a competent patient continues to object to the procedure, or if a conclusive determination of capacity is not feasible, the examination should be terminated as soon as it is safe to do so. 10 Informed consent should be sufficiently detailed to cover all findings that can be reasonably anticipated during an endoscopic examination. The scope of this consent should not be expanded, nor a patient's implicit consent for additional interventions assumed, unless failure to proceed with such interventions would result in immediate and predictable harm to the patient.
- 9 August 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (10) , 952-966
Informed consent for endoscopic procedures: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
Main statements: All endoscopic procedures are invasive and carry risk. Accordingly, all endoscopists should involve the patient in the decision-making process about the most appropriate endoscopic procedure for that individual, in keeping with a patient’s right to self-determination and autonomy. Recognition of this has led to detailed guidelines on informed consent for endoscopy in some countries, but in many no such guidance exists; this may lead to variations in care and exposure to risk of litigation. In this document, the European Society of Gastrointestinal Endoscopy (ESGE) sets out a series of statements that cover best practice in informed consent for endoscopy. These statements should be seen as a minimum standard of practice, but practitioners must be aware of and adhere to the law in their own country. 1 Patients should give informed consent for all gastrointestinal endoscopic procedures for which they have capacity to do so. 2 The healthcare professional seeking consent for an endoscopic procedure should ensure that the patient has the capacity to consent to that procedure. 3 For patients who lack capacity, healthcare personnel should at all times try to engage with people close to the patient, such as family, friends, or caregivers, to achieve consensus on the appropriateness of performing the procedure. 4 Where a patient lacks capacity to provide informed consent, the best interest decision should be clearly documented in the medical record. This should include information about the capacity assessment, reason(s) that the decision cannot be delayed for capacity recovery (or if recovery is not expected), who has been consulted, and where relevant the form of authority for the decision. 5 There should be a systematic and transparent disclosure of the expected benefits and harms that may reasonably affect patient choice on whether or not to undergo any diagnostic or interventional endoscopic procedure. Information about possible alternatives, as well as the consequences of doing nothing, should also be provided when relevant. 6 The information provided on the benefit and harms of an endoscopic procedure should be adapted to the procedure and patient-specific risk factors, and the preferences of the patient should be central to the consent process. 7 The consent discussion should be undertaken by an individual who is familiar with the procedure and its risks, and is able to discuss these in the context of the individual patient. 8 Patients should confirm consent to an endoscopic procedure in a private, unrushed, and non-coercive environment. 9 If a patient requests that an endoscopic procedure be discontinued, the procedure should be paused and the patient's capacity for decision making assessed. If a competent patient continues to object to the procedure, or if a conclusive determination of capacity is not feasible, the examination should be terminated as soon as it is safe to do so. 10 Informed consent should be sufficiently detailed to cover all findings that can be reasonably anticipated during an endoscopic examination. The scope of this consent should not be expanded, nor a patient's implicit consent for additional interventions assumed, unless failure to proceed with such interventions would result in immediate and predictable harm to the patient.
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S14
Quality monitoring of gastroscopy and colonoscopy by means of ESGE QIC-app
Aims We wanted to assess the feasibility of the QIC-app to audit retrospectively gastroscopy and colonoscopy practice in a tertiary center. As a secondary goal, we wanted to calculate the administrative cost for this quality assessment in the absence of automated systems. Methods 300 gastroscopies and 300 colonoscopies, performed between 01-05-2021 and 01-07-2021, were retrieved from the electronic patient record system. Since therapeutic procedures are excluded for most quality indicators (PMs), we only selected diagnostic procedures, equally representing every endoscopist (n=11) in the study. These procedures were manually entered into the ESGE QIC-app by an independent collaborator, not performing endoscopies. The ESGE secretary provided an Excel file from the data entered through the QIC-app that was used for analysis. The time spent distributing procedures, entering and analyzing data was closely monitored to get an estimate of the budget needed for quality measurement. Results Table 1 depicts the audit results for the different domains and PMs revealing a better performance for colonoscopy compared to gastroscopy. The time spent on this study was 53 hours and 25 minutes. Calculated at an hourly wage of €20-30, this would amount to about €1,068.33 to €1,602.50 in costs. Conclusions The ESGE QIC-app allows monitoring quality of an endoscopy unit with a minimal financial and logistic effort. In addition it can provide to ESGE data to assess which PMs are less important if the prevalence is low. We found that, on parameters that automatically appear in a report, overall scores are clearly better. Accordingly, targets were met more frequently, which thus underlines the importance of standardized structured reporting systems ([Fig. 1]). Table 1: Results of colonoscopy and gastroscopy for the different domains Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S14
Quality monitoring of gastroscopy and colonoscopy by means of ESGE QIC-app
Aims We wanted to assess the feasibility of the QIC-app to audit retrospectively gastroscopy and colonoscopy practice in a tertiary center. As a secondary goal, we wanted to calculate the administrative cost for this quality assessment in the absence of automated systems. Methods 300 gastroscopies and 300 colonoscopies, performed between 01-05-2021 and 01-07-2021, were retrieved from the electronic patient record system. Since therapeutic procedures are excluded for most quality indicators (PMs), we only selected diagnostic procedures, equally representing every endoscopist (n=11) in the study. These procedures were manually entered into the ESGE QIC-app by an independent collaborator, not performing endoscopies. The ESGE secretary provided an Excel file from the data entered through the QIC-app that was used for analysis. The time spent distributing procedures, entering and analyzing data was closely monitored to get an estimate of the budget needed for quality measurement. Results Table 1 depicts the audit results for the different domains and PMs revealing a better performance for colonoscopy compared to gastroscopy. The time spent on this study was 53 hours and 25 minutes. Calculated at an hourly wage of €20-30, this would amount to about €1,068.33 to €1,602.50 in costs. Conclusions The ESGE QIC-app allows monitoring quality of an endoscopy unit with a minimal financial and logistic effort. In addition it can provide to ESGE data to assess which PMs are less important if the prevalence is low. We found that, on parameters that automatically appear in a report, overall scores are clearly better. Accordingly, targets were met more frequently, which thus underlines the importance of standardized structured reporting systems ([Fig. 1]). Table 1: Results of colonoscopy and gastroscopy for the different domains Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S10
Clinical validation of a computer-aided detection model for colorectal polyp detection (CAD-ARTIPOD) trial using a second observer and real-time unblinding
Aims This trial aimed to validate a CADe system for colorectal polyp detection versus trained endoscopists in an endoscopy blinded set-up with real-time unblinding. Methods The CAD-ARTIPOD trial is a prospective multicenter trial conducted in 9 European centers. CADe specifics were published earlier [1]. Sample size analysis for superiority required 2048 polyps assuming a difference in sensitivity of 2% with endoscopic diagnosis as gold standard. All endoscopists (ADR 20-50%) were blinded for the CADe output. A second observer classified in real time the CADe output in (1) true positive (detected/not detected by the endoscopist) (2) false negative or (3) clinically relevant or irrelevant false positive detection. If a polyp was only detected by CADe, the endoscopist was unblinded for confirmation of the finding. Histological assessment of endoscopically confirmed polyps was performed by two independent histopathologists. Results A number of 2080 polyps were collected, 1549 were histologically confirmed polyps. For the primary endpoint superiority was not reached between CADe and endoscopists (sensitivity (Sn) of 0.94 vs 0.96) (non-inferiority margin of 5%, p = 0.0216). False positive rate was 1.8/min. With histology as standard, CADe outperformed the endoscopists (Sn 0.96 versus 0.95 (p=0.03)) and showed an extra detection rate of 4.8% (Fig. [1]). Conclusions This manufacturer independent CADe system used in an innovative and competitive study design demonstrated non-inferiority in comparison to endoscopists’ polyp detection. However, with histology as gold standard CADe outperformed endoscopists. Our study also shows that “watching over a shoulder” in itself leads to higher PDR and ADR Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S10
Clinical validation of a computer-aided detection model for colorectal polyp detection (CAD-ARTIPOD) trial using a second observer and real-time unblinding
Aims This trial aimed to validate a CADe system for colorectal polyp detection versus trained endoscopists in an endoscopy blinded set-up with real-time unblinding. Methods The CAD-ARTIPOD trial is a prospective multicenter trial conducted in 9 European centers. CADe specifics were published earlier [1]. Sample size analysis for superiority required 2048 polyps assuming a difference in sensitivity of 2% with endoscopic diagnosis as gold standard. All endoscopists (ADR 20-50%) were blinded for the CADe output. A second observer classified in real time the CADe output in (1) true positive (detected/not detected by the endoscopist) (2) false negative or (3) clinically relevant or irrelevant false positive detection. If a polyp was only detected by CADe, the endoscopist was unblinded for confirmation of the finding. Histological assessment of endoscopically confirmed polyps was performed by two independent histopathologists. Results A number of 2080 polyps were collected, 1549 were histologically confirmed polyps. For the primary endpoint superiority was not reached between CADe and endoscopists (sensitivity (Sn) of 0.94 vs 0.96) (non-inferiority margin of 5%, p = 0.0216). False positive rate was 1.8/min. With histology as standard, CADe outperformed the endoscopists (Sn 0.96 versus 0.95 (p=0.03)) and showed an extra detection rate of 4.8% (Fig. [1]). Conclusions This manufacturer independent CADe system used in an innovative and competitive study design demonstrated non-inferiority in comparison to endoscopists’ polyp detection. However, with histology as gold standard CADe outperformed endoscopists. Our study also shows that “watching over a shoulder” in itself leads to higher PDR and ADR Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 15 December 2022
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 10 (12) , E1544-E1547
Implementation of the Aldrete score reduces recovery time after non-anesthesiologist-administered procedural sedation in gastrointestinal endoscopy
Background and study aims Procedural sedation and analgesia (PSA) by trained non-anesthesiologist physicians and/or nurses is often performed during endoscopic procedures. Discharge from the recovery area after monitored observation is frequently based on fixed time parameters or subjective clinical assessment. In this study, the effect of implementation of the Aldrete score on recovery time after procedural sedation was analyzed in a real-life setting. Patients and methods A prospective observational study of patients undergoing procedural sedation and analgesia during gastroscopy, colonoscopy or endoscopic ultrasound was performed. All procedures were randomly included to represent a real-life situation with different endoscopists, recovery nurses, endoscopy systems and indications. After a first observation period, all endoscopy nurses were trained to implement the Aldrete score when discharging patients, followed by a second observation period. Results During the first observation period, the average time spent in the recovery area was 59 ± 22 minutes after procedural sedation. After implementation of the Aldrete score, the recovery time decreased significantly to 47 ± 25 minutes (P < 0.01) with identical doses of procedural sedation and analgesia. The decrease in time was between 19 % and 35 % for the different endoscopic procedures. Conclusions Implementation of the Aldrete score after procedural sedation and analgesia significantly reduces the time spent in the recovery area. The score can be used to safely implement a discharge policy that provides more efficient and standardized management for an endoscopy service.
- 15 December 2022
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 10 (12) , E1544-E1547
Open AccessImplementation of the Aldrete score reduces recovery time after non-anesthesiologist-administered procedural sedation in gastrointestinal endoscopy
Background and study aims Procedural sedation and analgesia (PSA) by trained non-anesthesiologist physicians and/or nurses is often performed during endoscopic procedures. Discharge from the recovery area after monitored observation is frequently based on fixed time parameters or subjective clinical assessment. In this study, the effect of implementation of the Aldrete score on recovery time after procedural sedation was analyzed in a real-life setting. Patients and methods A prospective observational study of patients undergoing procedural sedation and analgesia during gastroscopy, colonoscopy or endoscopic ultrasound was performed. All procedures were randomly included to represent a real-life situation with different endoscopists, recovery nurses, endoscopy systems and indications. After a first observation period, all endoscopy nurses were trained to implement the Aldrete score when discharging patients, followed by a second observation period. Results During the first observation period, the average time spent in the recovery area was 59 ± 22 minutes after procedural sedation. After implementation of the Aldrete score, the recovery time decreased significantly to 47 ± 25 minutes (P < 0.01) with identical doses of procedural sedation and analgesia. The decrease in time was between 19 % and 35 % for the different endoscopic procedures. Conclusions Implementation of the Aldrete score after procedural sedation and analgesia significantly reduces the time spent in the recovery area. The score can be used to safely implement a discharge policy that provides more efficient and standardized management for an endoscopy service.
- 21 June 2022
- Published by Universa BV in Acta Gastro Enterologica Belgica
- Vol. 85 (4) , 625-631
Diagnosis and screening for anal intraepithelial neoplasia in Belgium: position statement
Anal cancer is an uncommon malignancy, comprising only 2.5% of all gastrointestinal malignancies and similar to cervical cancer, the human papillomavirus (HPV) is responsible for the majority of anal cancers. Over the last decades there has been an up to 3-fold increased incidence seen in specific populations at risk such as persons living with HIV (PLWH), men who have sex with men (MSM), woman diagnosed with HPV-related gynaecological precancerous lesions or cancer, solid organ transplant recipients (SOTR) and patients with autoimmune diseases. Although international practice is evolving increasingly towards active screening for and treatment of anal cancer precursors in at-risk groups, currently no organised screening program is in effect in Belgium. Currently, differerent screening options as well as treatment modalities are available. Before commencing a nationwide organised screening program, essential decisions on screening strategies need to be made, based on both scientific as well as financial and logistical facts.
- 21 June 2022
- Published by Universa BV in Acta Gastro Enterologica Belgica
- Vol. 85 (4) , 625-631
Diagnosis and screening for anal intraepithelial neoplasia in Belgium: position statement
Anal cancer is an uncommon malignancy, comprising only 2.5% of all gastrointestinal malignancies and similar to cervical cancer, the human papillomavirus (HPV) is responsible for the majority of anal cancers. Over the last decades there has been an up to 3-fold increased incidence seen in specific populations at risk such as persons living with HIV (PLWH), men who have sex with men (MSM), woman diagnosed with HPV-related gynaecological precancerous lesions or cancer, solid organ transplant recipients (SOTR) and patients with autoimmune diseases. Although international practice is evolving increasingly towards active screening for and treatment of anal cancer precursors in at-risk groups, currently no organised screening program is in effect in Belgium. Currently, differerent screening options as well as treatment modalities are available. Before commencing a nationwide organised screening program, essential decisions on screening strategies need to be made, based on both scientific as well as financial and logistical facts.
- 26 March 2022
- Published by Wiley in International Journal of Cancer
- Vol. 151 (1) , 156-157
Are heart transplant recipients more at risk for anal squamous carcinoma than other solid organ transplant recipients?
- 26 March 2022
- Published by Wiley in International Journal of Cancer
- Vol. 151 (1) , 156-157
Are heart transplant recipients more at risk for anal squamous carcinoma than other solid organ transplant recipients?